Chromosome 3p loss of heterozygosity is associated with a unique metabolic network in clear cell renal carcinoma.
about
Novel drugs that target the metabolic reprogramming in renal cell cancerTranscriptomics resources of human tissues andĀ organsApplications of Genome-Scale Metabolic Models in Biotechnology and Systems MedicineMathematical models of cancer metabolismReconstruction of Tissue-Specific Metabolic Networks Using CORDAIntegrative analysis of human omics data using biomolecular networks.Epigenetic alterations of chromosome 3 revealed by NotI-microarrays in clear cell renal cell carcinoma.Systematic Analysis of the Expression of the Mitochondrial ATP Synthase (Complex V) Subunits in Clear Cell Renal Cell Carcinoma.Flux balance analysis predicts essential genes in clear cell renal cell carcinoma metabolism.Succinate dehydrogenase inhibition leads to epithelial-mesenchymal transition and reprogrammed carbon metabolism.Kiwi: a tool for integration and visualization of network topology and gene-set analysisHuman metabolic atlas: an online resource for human metabolism.Modeling cancer metabolism on a genome scale.Synthetic dosage lethality in the human metabolic network is highly predictive of tumor growth and cancer patient survival.High expression of Solute Carrier Family 1, member 5 (SLC1A5) is associated with poor prognosis in clear-cell renal cell carcinomaPrimary clear cell renal carcinoma cells display minimal mitochondrial respiratory capacity resulting in pronounced sensitivity to glycolytic inhibition by 3-BromopyruvateAn Integrated Metabolic Atlas of Clear Cell Renal Cell Carcinoma.Control of fluxes in metabolic networks.Prognostic Value of Plasma and Urine Glycosaminoglycan Scores in Clear Cell Renal Cell Carcinoma.Personalized Prediction of Proliferation Rates and Metabolic Liabilities in Cancer Biopsies.Polypyrimidine Tract-Binding Protein 1 promotes proliferation, migration and invasion in clear-cell renal cell carcinoma by regulating alternative splicing of PKMIn search for symmetries in the metabolism of cancer.The proteomic landscape of renal tumors.(1)H NMR metabolomics analysis of renal cell carcinoma cells: Effect of VHL inactivation on metabolism.Identifying anti-growth factors for human cancer cell lines through genome-scale metabolic modeling.The Role of Glucose and Lipid Metabolism in Growth and Survival of Cancer Cells.A computational study of the Warburg effect identifies metabolic targets inhibiting cancer migration.Large-scale computational models of liver metabolism: How far from the clinics?Systems biology analysis of hepatitis C virus infection reveals the role of copy number increases in regions of chromosome 1q in hepatocellular carcinoma metabolism.A metabolic core model elucidates how enhanced utilization of glucose and glutamine, with enhanced glutamine-dependent lactate production, promotes cancer cell growth: The WarburQ effect.Modeling Renal Cell Carcinoma in Mice: Bap1 and Pbrm1 Inactivation Drive Tumor Grade.High truncated-O-glycan score predicts adverse clinical outcome in patients with localized clear-cell renal cell carcinoma after surgery.Restoration of type 1 iodothyronine deiodinase expression in renal cancer cells downregulates oncoproteins and affects key metabolic pathways as well as anti-oxidative system.A Landscape of Metabolic Variation across Tumor Types.The glucose and lipid metabolism reprogramming is grade-dependent in clear cell renal cell carcinoma primary cultures and is targetable to modulate cell viability and proliferation.High mucin-7 expression is an independent predictor of adverse clinical outcomes in patients with clear-cell renal cell carcinoma.Genomic features of renal cell carcinoma with venous tumor thrombus.Global isoform-specific transcript alterations and deregulated networks in clear cell renal cell carcinoma.The glutathione redox system is essential to prevent ferroptosis caused by impaired lipid metabolism in clear cell renal cell carcinoma
P2860
Q26740187-E030685B-8D01-4971-B2FD-4D475ED511DEQ26752519-30799DFE-9266-4892-806D-C84A95CFFD86Q26771504-8A1EB75B-4FB5-4720-90E9-E77AF118E6C8Q26772067-224F98AD-D63D-48CB-B2B4-1B35F66B22F5Q28388815-52FEE59B-1194-4AEC-B291-AAE40F98FBD5Q31120979-7DD51267-C834-4E47-9ECB-6AEE5512FB73Q33745551-27DF177F-44BD-48F8-810F-3465F7685840Q33869708-B58F8134-8384-4BF5-A66A-B73239C96BCDQ34044149-8939B7C6-1EBB-40E6-B056-0BF4EF6C3081Q35067274-7600B06F-5411-4B85-A86F-177EAF7DF701Q35510487-13588764-FC44-4626-B82A-CF4F7E1315D0Q35713056-73D55309-AA71-4BC7-905A-1D776A5DC985Q35850350-30ADB76D-3947-446C-A264-D54740A70900Q36120262-CE7D4114-150F-47A1-AD6E-12BBC510FFBDQ36310209-12619E46-ECAA-4099-BBF4-FC2D01A6FEB8Q36347081-7CFC7C10-DC32-48CA-AA41-9B45A9818350Q36732789-7BE62D30-0BA1-480C-931A-083CA1A3EF20Q37076979-605D7E27-3957-465B-BA1F-085FC3910C79Q37433431-628F749A-28D2-4310-B797-7DEB1EB6F2AEQ37532946-2561172C-B3D4-459A-8A6E-8171000C9C2DQ37679992-AE05C5AA-44F9-4031-ACDA-CFD90C57457EQ38625561-E5ADD0D6-FE23-4297-844E-EE5CD6530B59Q38803559-25487F2C-EB7B-47CC-B473-A27900533FFBQ38815713-4DC248DC-FF46-4B1B-A70D-6C81C81841F0Q38914252-DECDDA33-D4E1-4562-9A1E-17AE0056F9A7Q38936241-5EA482DE-CB99-4EFC-881E-4679E01A61F0Q38969397-52C98503-02DB-41A9-9858-5AC2C1B6D3B2Q39315101-6A17537A-1880-4098-8AB3-63E0B63BA4B8Q40730329-D60D772B-0B9A-41CF-AECF-2BB8B01C9C4EQ42706654-666266DA-F996-4BAE-AB62-D8701E79C650Q46856592-A8E2767F-9BC7-4D55-9C0E-202C2834E55FQ47119117-7B6CBF83-0FA1-41B8-B0F7-22567A6E983AQ47173796-39985E93-4007-468B-8361-110B025F18C2Q49359410-3A4AE88C-E180-42DB-9D92-480800DD38E3Q49678727-4BBF71ED-ABFD-4644-A3BC-74913804716DQ51451231-D6C72709-63F4-485A-9DDC-428FE07C0780Q55024664-3AA30CD6-26EF-416D-A598-0B4E3A58C2B0Q55172634-CB84F23F-8254-4D6B-9055-D9A7403A939EQ57903458-38AACF07-656B-4D18-A707-4764A01B9F5B
P2860
Chromosome 3p loss of heterozygosity is associated with a unique metabolic network in clear cell renal carcinoma.
description
2014 nĆ® lÅ«n-bĆ»n
@nan
2014 Õ©ÕøÖÕ”ÕÆÕ”Õ¶Õ« ÕÕ„ÕæÖÕøÖÕ”ÖÕ«Õ¶ Õ°ÖÕ”ÕæÕ”ÖÕ”ÕÆÕøÖÕ”Õ® Õ£Õ«ÕæÕ”ÕÆÕ”Õ¶ ÕµÖ
Õ¤ÕøÖÕ”Õ®
@hyw
2014 Õ©Õ¾Õ”ÕÆÕ”Õ¶Õ« ÖÕ„ÕæÖÕ¾Õ”ÖÕ«Õ¶ Õ°ÖÕ”ÕæÕ”ÖÕ”ÕÆÕ¾Õ”Õ® Õ£Õ«ÕæÕ”ÕÆÕ”Õ¶ Õ°ÕøÕ¤Õ¾Õ”Õ®
@hy
2014幓ć®č«ę
@ja
2014幓č«ę
@yue
2014幓č«ę
@zh-hant
2014幓č«ę
@zh-hk
2014幓č«ę
@zh-mo
2014幓č«ę
@zh-tw
2014幓č®ŗę
@wuu
name
Chromosome 3p loss of heterozy ...... in clear cell renal carcinoma.
@ast
Chromosome 3p loss of heterozy ...... in clear cell renal carcinoma.
@en
Chromosome 3p loss of heterozy ...... in clear cell renal carcinoma.
@nl
type
label
Chromosome 3p loss of heterozy ...... in clear cell renal carcinoma.
@ast
Chromosome 3p loss of heterozy ...... in clear cell renal carcinoma.
@en
Chromosome 3p loss of heterozy ...... in clear cell renal carcinoma.
@nl
prefLabel
Chromosome 3p loss of heterozy ...... in clear cell renal carcinoma.
@ast
Chromosome 3p loss of heterozy ...... in clear cell renal carcinoma.
@en
Chromosome 3p loss of heterozy ...... in clear cell renal carcinoma.
@nl
P2860
P50
P356
P1476
Chromosome 3p loss of heterozy ...... in clear cell renal carcinoma.
@en
P2860
P304
P356
10.1073/PNAS.1319196111
P407
P577
2014-02-18T00:00:00Z